Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
T2 Biosystems revenue
T2 Biosystems's revenue is $7.2 million.
What is T2 Biosystems's revenue?
- T2 Biosystems's revenue growth from 2013 to 2023 is 2,604.14%.
- T2 Biosystems has 182 employees, and the revenue per employee ratio is $39,521.
- T2 Biosystems's peak quarterly revenue was $7.8M in 2020(q4).
- T2 Biosystems peak revenue was $28.1M in 2021.
- T2 Biosystems annual revenue for 2022 was 22.3M, -20.5% growth from 2021.
- T2 Biosystems annual revenue for 2023 was 7.2M, -67.75% growth from 2022.
On this page
Zippi applies for you, and finds you a job.
T2 Biosystems historical revenue
T2 Biosystems's peak revenue was $28.1M in 2021. The peak quarterly revenue was $7.8M in 2020(q4).
T2 Biosystems's revenue increased from $266.0k in 2013 to $7.2M currently. That's a 2,604.14% change in annual revenue.
T2 Biosystems annual revenue
T2 Biosystems annual revenue over time
| Fiscal year / year | T2 Biosystems revenue |
|---|---|
| 2013 | $266,000 |
| 2014 | $119,000 |
| 2015 | $2.8M |
| 2016 | $4.1M |
| 2017 | $4.7M |
| 2018 | $10.5M |
| 2019 | $8.3M |
| 2020 | $18.1M |
| 2021 | $28.1M |
| 2022 | $22.3M |
| 2023 | $7.2M |
How accurately did T2 Biosystems' revenue projections match actual performance?
T2 Biosystems annual growth
T2 Biosystems saw the greatest revenue growth in 2015, when revenue increased by 2,263.87%.
T2 Biosystems had the lowest revenue growth in 2014, when revenue changed by -55.26%.
T2 Biosystems annual growth rate over time
| Year | T2 Biosystems growth |
|---|---|
| 2014 | -55%↓ |
| 2015 | 2264%↑ |
| 2016 | 45%↑ |
| 2017 | 14%↑ |
| 2018 | 125%↑ |
| 2019 | -21%↓ |
| 2020 | 118%↑ |
| 2021 | 55%↑ |
| 2022 | -21%↓ |
| 2023 | -68%↓ |
T2 Biosystems quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
T2 Biosystems quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | - | - | - | $119,052 |
| 2015 | $188,000 | $564,000 | $1.0M | $1.0M |
| 2016 | $1.1M | $990,000 | $1.1M | $909,000 |
| 2017 | $941,000 | $956,000 | $1.1M | $1.7M |
| 2018 | $2.3M | $3.9M | $2.5M | $1.8M |
| 2019 | $1.8M | $1.8M | $1.7M | $3.1M |
| 2020 | $2.5M | $2.6M | $5.2M | $7.8M |
| 2021 | $7.0M | $6.7M | $7.4M | $7.0M |
| 2022 | $7.2M | $5.9M | $3.7M | $5.5M |
| 2023 | $2.1M | $2.0M | $1.5M | $1.7M |
| 2024 | $2.1M | $2.0M | $2.0M | - |
T2 Biosystems jobs nearby
Do you work at T2 Biosystems?
Is T2 Biosystems transparent about its revenue structure?
T2 Biosystems financial information
| CEO | John J. Sperzel |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 182 |
| Date Founded | 2006 |
| Headquarters | Lexington, Massachusetts |
| Number of Locations | 2 |
| Revenue | $7.2M |
| Net Income | -$62,003,000 |
| Gross Proft | ($8.2M) (2023) |
| PE Ratio | -3.88 |
| Market Capitalization | $194.3M |
| Total Assets | $34,327,000 |
| Ticker | TTOO |
T2 Biosystems jobs you might like
T2 Biosystems financing
T2 Biosystems received early financing of $5.5M on 2006-01-01.
| Series | Round size | Date |
|---|---|---|
| Series A | $5.5M | 01/2006 |
| Convertible Note | $500K | 05/2008 |
| Series B | $10.8M | 10/2008 |
| Series C | $15M | 05/2010 |
| Series D | $23M | 08/2011 |
| Series E | $40M | 03/2013 |
| Post Ipo Equity | $34.1M | 12/2015 |
| Post Ipo Equity | $40M | 09/2016 |
| Post Ipo Debt | $50M | 12/2016 |
| Grant | $2M | 03/2018 |
| Grant | $69M | 09/2019 |
T2 Biosystems investors
| Investors | Security type |
|---|---|
| Polaris Partners | Series A |
| Flybridge | Series A |
| Flagship Pioneering Inc | Series A |
| Flybridge | Convertible Note |
| Polaris Partners | Series B |
| Flybridge | Series B |
| In Q Tel | Series B |
| Partners HealthCare | Series B |
| Flagship Pioneering Inc | Series B |
| Physic Ventures | Series C |
| Polaris Partners | Series C |
| WS Investments | Series C |
| Arcus Ventures | Series C |
| Flybridge | Series C |
| Camros Capital LLC | Series C |
| RA Capital Management | Series C |
| Partners HealthCare | Series C |
| Flagship Pioneering Inc | Series C |
| Physic Ventures | Series D |
| Polaris Partners | Series D |
| WS Investments | Series D |
| Flybridge | Series D |
| Arcus Ventures | Series D |
| Camros Capital LLC | Series D |
| RA Capital Management | Series D |
| Partners HealthCare | Series D |
| Flagship Pioneering Inc | Series D |
| Aisling Capital | Series D |
| The Goldman Sachs Group, Inc. | Series E |
| Physic Ventures | Series E |
| Polaris Partners | Series E |
| WS Investments | Series E |
| Flybridge | Series E |
| Arcus Ventures | Series E |
| Camros Capital LLC | Series E |
| Flagship Pioneering Inc | Series E |
| Partners Healthcare Group | Series E |
| Aisling Capital | Series E |
| Canon Inc. | Post Ipo Equity |
| CRG LP | Post Ipo Debt |
| CARB X | Grant |
| Biomedical Advanced Research and Development Authority (BARDA) | Grant |
T2 Biosystems competitors
T2 Biosystems's top competitor, Regeneron, earned an annual revenue of $14.2B.
T2 Biosystems's smallest competitor is Rennova Health with revenue of $10.6M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| CardioMEMS | $49,099 | $10.6M | 50 | - |
| Digirad | $63,766 | $120.7M | 618 | - |
| Luminex | $73,985 | $417.4M | 1,140 | 4 |
| Rennova Health | $45,967 | $10.6M | 99 | 1 |
| Symmetry Surgical | $45,313 | $84.5M | 192 | - |
| Emergent BioSolutions | $77,521 | $1.6B | 1,834 | 11 |
| Medimmune | $78,540 | $422.2M | 6,030 | - |
| Regeneron | $85,589 | $14.2B | 9,123 | 317 |
| Fujirebio Europe | $63,212 | $94.8M | 7,500 | - |
| 454 Life Sciences | $54,620 | $19.4M | 100 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
T2 Biosystems highest paying jobs
Zippia gives an in-depth look into the details of T2 Biosystems, including salaries, political affiliations, employee data, and more, in order to inform job seekers about T2 Biosystems. The employee data is based on information from people who have self-reported their past or current employments at T2 Biosystems. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by T2 Biosystems. The data presented on this page does not represent the view of T2 Biosystems and its employees or that of Zippia.
T2 Biosystems may also be known as or be related to T2 BIOSYSTEMS INC., T2 Biosystems, T2 Biosystems Inc and T2 Biosystems, Inc.